Reed Elsevier PT Raised to $11.95 at JPMorgan Chase (REL)
Equities research analysts at JPMorgan Chase upped their price target on shares of Reed Elsevier (LON: REL) from $10.30 (685 GBX) to $11.95 (795 GBX) in a research note issued to investors on Friday. The firm currently has an “overweight” rating on the stock.
A number of other analysts have also recently weighed in on REL. Analysts at JP Morgan Cazenove cut their price target on shares of Reed Elsevier from $11.95 to $10.30 in a research note to investors on Thursday. They now have an “overweight” rating on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Reed Elsevier in a research note to investors on Thursday, February 28th. They now have a $11.41 price target on the stock. Finally, analysts at Investec Securities reiterated a “buy” rating on shares of Reed Elsevier in a research note to investors on Thursday, February 28th. They now have a $11.71 price target on the stock.
Shares of Reed Elsevier traded up 0.48% during mid-day trading on Friday, hitting GBX 732.50. Reed Elsevier has a one year low of GBX 466.10 and a one year high of GBX 742.00. The stock’s 50-day moving average is currently GBX 599.8. The company’s market cap is £8.820 billion.
Reed Elsevier PLC is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
